Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Asset Utilization Ratio (2020 - 2025)

Goldenwell Biotech's Asset Utilization Ratio history spans 6 years, with the latest figure at 0.0 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 131.89% year-over-year to 0.0; the TTM value through Sep 2025 reached 0.0, down 131.89%, while the annual FY2024 figure was 0.0, 92.02% down from the prior year.
  • Asset Utilization Ratio reached 0.0 in Q3 2025 per GWLL's latest filing, up from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.22 in Q2 2023 to a low of 0.0 in Q2 2025.
  • Average Asset Utilization Ratio over 5 years is 0.05, with a median of 0.01 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: soared 329947.56% in 2022, then tumbled 131.89% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.04 in 2021, then skyrocketed by 383.91% to 0.19 in 2022, then tumbled by 93.93% to 0.01 in 2023, then crashed by 100.83% to 0.0 in 2024, then tumbled by 611.56% to 0.0 in 2025.
  • Per Business Quant, the three most recent readings for GWLL's Asset Utilization Ratio are 0.0 (Q3 2025), 0.0 (Q2 2025), and 0.0 (Q1 2025).